We are located in a beautiful
area known as the Ozarks

Medavera, Inc.
1200 E. Woodhurst, Building L-100
Springfield, MO 65804

Phone: 417.890.9722

For content questions:
Jill A. Sellers, BSPharm, PharmD
jill@medavera.com

For certificate and general questions:
Carrie Vause, MS
carrie@medavera.com

Office Image
CONTACT US
SEND THIS FORM
THE MEDICAL NEWS
Measles infected nearly 10 million people in 2018 and killed 140,000, mostly children, as devastating outbreaks of the viral disease hit every region of the world, the World Health Organization said on Thursday.... North Korea, one of the world's most reclusive states, plans to branch out into medical tourism next year, offering foreign visitors, most likely from China, treatments including cataract surgery, dental implants and therapy for tumors.... The U.S. Food and Drug Administration is investigating whether the diabetes drug metformin had unsafe levels of a cancer-causing chemical and will recommend recalls as appropriate, the agency said on Thursday.... A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys Therapeutics Inc in exchange for prescribing his patients an addictive fentanyl spray the drug manufacturer produced.... Biogen Inc on Thursday laid out more data on its experimental Alzheimer's drug that raised no major safety alarms but also offered little compelling evidence the drug, once declared a failure, actually works.... (Reuters Health) - One in every three high schools in the U.S. has no access to an athletic trainer, according to a large study.... (Reuters Health) - Although hospitals can improve financially when they join larger health systems, the merger may also reduce access to services for patients in rural areas, according to a new study.... The U.S. Food and Drug Administration on Thursday approved three generic versions of Swiss drugmaker Novartis AG's top-selling multiple sclerosis (MS) medicine Gilenya.... U.S. healthcare spending recovered in 2018 after two consecutive years of decline, a government health agency reported on Thursday.... (Reuters Health) - Trainee doctors often miss out on routine medical care and preventive health services even when they take daily prescriptions, a small study suggests.... (Reuters Health) - Hairdressers may have skin damage from a hair dye ingredient even when they don't have dermatitis, or rashes, from this exposure, a small lab experiment suggests.... A 34-year-old British hiker was revived in Spain after a six-hour cardiac arrest brought on by severe hypothermia, with the low mountain temperatures that made her ill also helping to save her life in what a doctor described as an "exceptional case".... U.S. health officials on Thursday reported one new case and one more death from a respiratory illness tied to vaping over a two-week period, taking the total death toll to 48.... Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing.... Sage Therapeutics Inc said on Thursday its experimental fast-acting drug aimed at treating severe depression failed a closely-watched study, sending shares down 60% and erasing about $4.6 billion of the drugmaker's market value.... Novartis research head Jay Bradner said on Thursday the Swiss drugmaker is focusing efforts against spinal muscular atrophy (SMA) on gene therapy Zolgensma and retreating from oral therapy like its molecule LMI070, also called branaplam.... - A stockpile of 500,000 doses of Ebola vaccine for emergency use in outbreaks of the deadly fever is being established by the global vaccine alliance GAVI.... GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval for fostemsavir, an experimental treatment for HIV in adults.... A measles epidemic in the Democratic Republic of Congo has killed 5,000 people this year, many of them young children, the World Health Organization (WHO) said on Thursday.... U.S. drugmaker Eli Lilly and Co said on Thursday it will create a new cancer research division that will be run by top executives from Loxo Oncology, a cancer-focused biotech company it acquired earlier this year....